Reuters logo
BRIEF-Presbia says anticipates submitting PMA to FDA in Q4 of 2017
May 23, 2017 / 9:17 PM / 4 months ago

BRIEF-Presbia says anticipates submitting PMA to FDA in Q4 of 2017

May 23 (Reuters) - Presbia Plc

* Presbia plc - through may 19, 2017, 421 subjects have undergone insertion of co’s microlens during staged pivotal clinic trial -sec filing

* Presbia plc - anticipates submitting pma to fda in q4 of 2017 Source text for Eikon: (bit.ly/2qhAIyr) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below